Biolidics Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was SGD 0.113 million compared to SGD 0.221 million a year ago. Net loss was SGD 0.609 million compared to SGD 1.09 million a year ago. Basic loss per share from continuing operations was SGD 0.0011 compared to SGD 0.0041 a year ago. Diluted loss per share from continuing operations was SGD 0.0011 compared to SGD 0.0041 a year ago.
For the six months, sales was SGD 1.2 million compared to SGD 0.685 million a year ago. Net loss was SGD 0.952 million compared to SGD 2.29 million a year ago. Basic loss per share from continuing operations was SGD 0.0018 compared to SGD 0.0086 a year ago. Diluted loss per share from continuing operations was SGD 0.0018 compared to SGD 0.0086 a year ago.